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Multiple intracellular signals arealtered inAlzheimer’s diseasebrain
tissues, including the PI3K/Akt pathway. However, the pathological
relevance of such alterations is poorly understood. In vitro studies
yield results that seem to be consistent with the conventional per-
ception inwhich an up-regulation of the cell survival pathway, PI3K
pathway, is protective in Alzheimer’s disease pathogenesis. The
current in vivo genetic approach, however, reveals that inhibition
of the PI3Kpathway leads to rescuingof the β-amyloid peptide (Aβ)-
inducedmemory loss in theDrosophila brain.We began our inquiry
into the molecular basis of this memory loss by studying Aβ42-
induced enhancement of long-term depression. We found that
long-term depression is restored to a normal level through inhibi-
tion of PI3K activity. Aβ42-induced PI3K hyperactivity is directly con-
ﬁrmed by immunostaining of the PI3K phosphorylation targets,
phospholipids. Such observations lead to the following demonstra-
tion thatAβ42-inducedmemory loss canbe rescued throughgenetic
silencing or pharmacological inhibition of PI3K functions. Our data
suggest thatAβ42stimulatesPI3K,which in turn causesmemory loss
in associationwith an increase in accumulation of Aβ42 aggregates.
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Two major clinical symptoms of Alzheimer’s disease (AD)include early memory loss and massive late-onset neuro-
degeneration. Genetic studies of the early onset familial AD
provide a causative link between AD and beta-amyloid (Aβ)
peptides that are derived from a proteolytic cleavage of the amy-
loid precursor protein (APP) (1–3). A body of evidence suggests
that Aβ peptides are capable of modifying a number of bio-
chemical pathways, such as PI3K, C-Junk, caspase, cyclin-
dependent kinase 5 (cdk5), and others (4, 5).An alteration in these
pathwaysmay lead to a wide range of cellular dysfunctions, such as
disturbed metal ion homeostasis, Ca2+ dysregulation, and
impaired neurotransmission. However, how Aβ42 alters these
signaling pathways is still unclear. Furthermore, because most of
these studies are performed in in vitro or semi in vivo preparations,
the relevance of any of these alterations to pathological pheno-
types is not well-studied.
We sought to gain insights into the biochemical processes that
mediate the Aβ toxicity through in vivo study of Aβ42-transgenic
fruit ﬂies. Expression of human APP or Aβ in theDrosophila brain
recapitulates many features of AD (6). Our previous study has
shown that expression of a secretory form of Aβ42 in the ﬂy brain
could induce age-dependent memory loss, massive neurodegen-
eration, accumulation of Aβ42 oligomers, and ﬁbril deposits (7, 8).
Because the APP family proteins and Aβ42 produce similar path-
ologic phenotypes across a wide range of organisms from inverte-
brates to mammals, the molecular basis of Aβ42 toxicity is likely
conserved (9–12). An APP-like (APPL) Drosophila protein has
been reported to give rise to a cleaved peptide capable of forming
amyloidogenic deposits and causing neurodegeneration (11).
This study focuses on the biochemical pathways through which
Aβ42 induces an age-dependent memory loss. An earlier study
reported that Aβ42 alters long-term depression (LTD) at the
larval neuromuscular junction (NMJ) (13). In Drosophila, this
preparation is the only one suitable for quantitative analysis of
synaptic transmission at identiﬁed synapses (14, 15). Although
LTD at the NMJ is not related with the memory formation,
its underlying regulatory molecular mechanisms may share sim-
ilar components, because many learning and memory mutants
show altered synaptic plasticity at the NMJ (16). Indeed, the
observations obtained at the NMJ led us to show that increased
PI3K activity contributes to the Aβ42-induced memory loss, and
this memory loss could be prevented through inhibition of
PI3K activity.
Results
As indicated earlier, we wanted to begin our searching of
molecular events underlying the Aβ42-induced memory loss
from analysis of LTD. The two-electrode voltage-clamp method
was used to investigate synaptic plasticity at the larval body wall
NMJ, which has been extensively characterized (14, 15). Various
forms of synaptic plasticity can be elicited at this glutamatergic
synapse (16, 17), including short-term facilitation, posttetanic
potentiation, and LTD. Although LTD in larval NMJ is mainly
expressed at the presynaptic site, which is different from other
preparations in which LTD is expressed at both pre- and post-
synaptic sites, the properties of LTD are quite similar to those of
vertebrate preparations (17). We have reported that LTD is
strongly reduced in the akt mutants, but this defect can be res-
cued by acute expression of the normal akt transgene (17). Our
previous work has shown that extracellular accumulation of
Aβ42 aggregates leads to enhanced LTD (13), and this is shown
again in the current study (Fig. 1A). The enhancement was mild
but consistent and statistically signiﬁcant. Because the observed
LTD is known to be regulated by Akt (17), which is a down-
stream target of PI3K, we decided to investigate if Aβ42-induced
LTD enhancement is related to the PI3K/Akt pathway.
With a tetanic stimulation, LTD was reliably elicited, and
enhancement of LTD was evident in larvae with targeted
expression of Aβ42 in muscle cells (G7/+;UAS-Aβ42/+) (Fig.
1A), presumably resulting from secretion of Aβ42 ﬁbril aggre-
gates (13). Aβ42 expression in presynaptic motor neurons has no
observable effects on LTD, likely because of secretion of dif-
ferent forms of aggregates compared with muscle cells (13).
Application of 25 nM wortmannin, a PI3K-speciﬁc inhibitor, to
the NMJ reduced LTD to the control level in Aβ42-expressing
larvae (Fig. 1B), suggesting that Aβ42-induced LTD enhance-
ment resulted from elevated PI3K activity.
To verify this conclusion with more direct observations, we
moved on to determine levels of PI3K phosphorylation targets,
Author contributions: H.-C.C., L.W., and Y.Z. designed research; H.-C.C., L.W., Z.X., and
A.Y. performed research; H.-C.C. and L.W. contributed new reagents/analytic tools; H.-C.C.,
L.W., and Y.Z. analyzed data; and H.-C.C., L.W., and Y.Z. wrote the paper.
The authors declare no conﬂict of interest.
This article is a PNAS Direct Submission.
1H.-C.C. and L.W. contributed equally to this work.
2To whom correspondence should be addressed. E-mail: zhongyi@cshl.edu.
This article contains supporting information online at www.pnas.org/cgi/content/full/
0909314107/DCSupplemental.
7060–7065 | PNAS | April 13, 2010 | vol. 107 | no. 15 www.pnas.org/cgi/doi/10.1073/pnas.0909314107
phosphatidylinositol-3,4-bisphosphate (Pi3,4P) and phosphati-
dylinositol-3,4,5-trisphosphate (Pi3,4,5P), through immunos-
taining but in a larval ventral ganglion preparation. This
preparation allowed a study of more general neuronal effects of
Aβ42 instead of conﬁning study to the NMJ. Moreover, this
preparation is suitable for studying the effects of intended drug
treatment (18, 19). Vertebrate insulin is known to activate Dro-
sophila receptors of insulin-like peptides that are coupled to
PI3K (20). We, therefore, incubated vertebrate insulin with
isolated larval ventral ganglion and quantiﬁed the level of
phospholipids using ﬂuorescence intensity ratios obtained by
immunostaining with speciﬁc antibodies (Fig. 2A). Single cells in
the ganglion with strong ﬂuorescence and well-deﬁned bounda-
ries were chosen for measuring the ratio of peripheral over
central ﬂuorescence intensities (Fig. 2B Upper). This ratio was
used to reﬂect the phospholipid level and thereby, the PI3K
activity. We found that the basal levels of both Pi3,4P (Fig. 2 A
and B) and Pi3,4,5P (Fig. S1 A and B) were increased in Aβ42-
expressing neurons (elav/Y;UAS-Aβ42/+) compared with the
controls (elav/Y;+/+). This increase is suppressed by application
of wortmannin (Fig. 2 A and B). In contrast, insulin was capable
of stimulating an increase in the targeted phospholipids in the
controls, but it failed to further elevate them in Aβ42-expressing
neurons (Fig. 2 A and B and Fig. S1 A and B). Thus, PI3K is
indeed stimulated by Aβ42 expression.
Using different techniques, we have shown PI3K hyperactivity
both at the NMJ and in the ventral ganglion, indicating that ele-
vated PI3K activity may be a general feature of Aβ42 expression in
neurons. It prompted our effort in testing if the observed PI3K
hyperactivity contributed to the memory deﬁcits observed in
Aβ42-expressing adult fruit ﬂies. With an extensively charac-
terized Pavlovian olfactory aversive conditioning (Methods), our
previous studies showed that 2-day-old Aβ42-expressing adult
ﬂies (elav/Y;UAS-Aβ42/+) have a normal immediate memory (7,
8), but a signiﬁcant defect of this immediate memory occurs as
early as 5 days (Fig. 3A andB) and is also detectable in 10- and 15-
day-old ﬂies (Fig. S2). However, it is unsuitable to use ﬂies older
than 15 days for the memory assay, because these animals display
Aβ42-induced locomotion defects (7). We chose 5-day-old ﬂies
for testing the effects of genetic manipulations, because the Aβ42-
induced memory phenotype at this age was still in progression,
making it is possible to observe both ameliorated and exacerbated
memories in Aβ42-expressing ﬂies. The Aβ42-induced age-
dependent memory loss was prevented by knocking-down P60,
the regulatory subunit of PI3K, through RNA interference (elav/
Y;UAS-Aβ42/+;UAS-dp60 RNAi/+) (Fig. 3A). Additionally, a
better memory was observed in 10- or even 15-day-old Aβ42-
expressing ﬂies with silenced PI3K function (Fig. S2). The sig-
niﬁcance of this observation was strengthened by the improved
memory in Aβ42-expressing ﬂies with overexpression of the
phosphatase and tensin homolog (PTEN), a negative regulator of
PI3K (elav/Y;UAS-Aβ42/+;UAS-dpten/+) (Fig. 3B). Conversely,
Aβ42-induced memory loss was enhanced in 5-day-old female
ﬂies with an overexpression of a dominant negative mutant
PTENC124S, which is a catalytically inactive form of PTEN (elav/
+;UAS-Aβ42/+;UAS-ptenC124S/+) (Fig. 3C). Female ﬂies were
used in this particular experiment, because female Aβ42-
expressing ﬂies at this age showed a milder memory-loss pheno-
type compared with adult males because of the gene-dosage effect
(7). Therefore, the enhanced memory loss was more easily
revealed. Inhibition of PI3K with P60 RNAi or overexpressed
PTEN alone had no signiﬁcant effect on memory performance,
although overexpression of PTENC124S showed a mild but sig-
niﬁcant reduction in memory scores (Fig. S3 A and B). Flies of all
genotypes showed normal sensorimotor ability (Table S1). Taken
together, the Aβ42-induced memory loss can be rescued through
inhibition of PI3K hyperactivity through genetic manipulations.
To exclude potential developmental effects associated with
genetic manipulations of PI3K activity before eclosion, we
Fig. 1. Aβ42-enhanced LTD is reversed by application of the PI3K inhibitor
at the NMJ. (A and B) Third-instar larvae were used for electrophysiology
analysis. Evoked junctional currents (EJCs) were recorded in 0.4 mM Ca2+
saline. LTD was induced by tetanic stimulation of 30 Hz for 20 seconds.
Representative EJCs traces (Left, scale is 10 nA vertical and 7.5 ms horizontal)
for each genotype are normalized to the basal level before tetanic stim-
ulation (Center). (A Right) LTD is enhanced after expression of Aβ42 driven
by G7-Gal4 (G7/+; UAS-Aβ42/+) compared with control (G7/+; +/+) (means ±
SEM; t test; *P < 0.05; n = 5). (B Right) Application of 25 nM wortmannin, the
PI3K inhibitor, during test could reverse the Aβ42-induced LTD enhancement
to the same level as the control (means ± SEM; n = 6).
Fig. 2. Expression of Aβ42 increases the PI3,4P level through activation of the
PI3K activity. (A) Larval ventral ganglion neurons from control (elav/Y;+/+) and
Aβ42-expressing (elav/Y;UAS-Aβ42/+) ﬂies were ﬁxed and stained with anti-
PI3,4P antibody without treatment (basal) or after 30 minutes of treatment
with 1.7 μM insulin or 100 nM wortmannin (Wort), respectively. (B Upper)
Single cells with strong ﬂuorescence and well-deﬁned boundaries were
chosen for measuring the ratio of the plasma membrane ﬂuorescence inten-
sity (arrows) and the cytosolic ﬂuorescence intensity (star). (Lower) The ﬂuo-
rescence ratio of each group of neurons is presented. The PI3,4P level was
signiﬁcantly increased in Aβ42-expressing neurons compared with control
neurons without treatment (t test; *P < 0.05). This Aβ42-induced phenotype
was reversed after wortmannin treatment. Incubation with insulin increased
the Pi3,4P level in control neurons (t test; *P< 0.05) but not inAβ42-expressing
neurons compared with those without treatment. Data are expressed as
means± SEM (n= 30, 15, and 15 cells for nontreatment, insulin treatment, and
wortmannin treatment, respectively). (Scale bar, 10 μm.)
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looked at effects of a pharmacological treatment of wortmannin,
the PI3K inhibitor, on adult male ﬂies. Two drug-feeding para-
digms were tested. For the ﬁrst paradigm, drug feeding began
with 2-day-old ﬂies, before any observable behavioral defects, for
4 h each day for 7 consecutive days. The memory scores were
determined on day 10 (Fig. 3D Right). Improved memory was
seen in Aβ42-expressing ﬂies with 100 nM, but not 25 nM, drug
treatment (Fig. 3D Left). This result was conﬁrmed with another
PI3K inhibitor, LY294002 (Fig. S4).
The second drug feeding (wortmannin, 100 nM) test began at
day 5 after eclosion when memory was signiﬁcantly lower in
Aβ42-expressing ﬂies (Fig. 3 A and B), and it continued for 7
days. Then, memory was assayed on day 13 (Fig. S5A Upper).
Memory was signiﬁcantly better in Aβ42-expressing ﬂies with the
drug treatment compared with those treated with sucrose (Fig.
S5A). Both paradigms of the drug treatment used in this study
did not inﬂuence the sensorimotor ability of Aβ42-expressing
ﬂies (Table S2). The rescuing effect conﬁrmed that the Aβ42-
induced memory loss resulted from an elevated PI3K activity.
To gain insights into how PI3K contributes to Aβ42-induced
phenotypes, we evaluated accumulation of Aβ42 aggregates. Aβ
peptides accumulate in different forms, including monomer,
oligomers, and ﬁbrils. Aβ oligomers have recently come into
focus as the major pathological species of Aβ peptides, and they
can cause learning defects in mice (3, 21, 22). To determine the
oligomer level, whole-head lyses were used for the Western blot
assay. For stronger signals, 15-day-old male ﬂies were chosen
(older ﬂies have higher levels of accumulated Aβ42). Here, we
found that the ratio of oligomers (dimmers and trimmers; see
bands pointed by two arrows in Fig. 4 Left) to monomer (pointed
by the arrow head in Fig. 4) was signiﬁcantly lower in Aβ42-
expressing ﬂies with inhibition of PI3K activity through either
knocking-down P60 or overexpression of PTEN (Fig. 4). Note
that the Aβ42 monomer level was not affected (Fig. S6). How-
ever, we must point out that the reduction in the oligomer level
was moderate. A similar level of reduction was also observed in
13-day-old Aβ42-expressing ﬂies after the drug (wortmannin)
treatment (Fig. S5B).
Thioﬂavin-S (TS) staining of the whole brain was used to
speciﬁcally visualize the Aβ42 ﬁbril deposits (Fig. 5A) (8, 23).
This analysis was performed in two different age groups: 15-day-
old ﬂies, at which immediate memory and accumulation of
oligomers were measured, and 50-day-old ﬂies, at which exten-
sive neurodegeneration has been reported (8). Our examination
focused on the mushroom-body (MB) region, because it is easily
identiﬁed anatomically and is considered to be a neural center
for olfactory associative-memory formation in fruit ﬂies.
In contrast to the fairly moderate reduction in oligomer levels,
we were surprised to see that ﬁbril Aβ42 deposits were dramat-
ically reduced by inhibition of PI3K activity. We classiﬁed the
deposits into three categories on basis of size: 1–1.5 μm, 1.5–2
μm, and >2 μm in diameter. The deposits grew larger in size with
age. Inhibition of PI3K activity through knocking down the P60
subunit in elav/Y;UAS-Aβ42/+;UAS-dp60 RNAi/+ transgenic
ﬂies led to a drastic reduction in the number of deposits. For
younger ﬂies, the reduction occurred in the smaller deposits,
whereas for older ﬂies, the reduction was mainly on the larger
deposits (Fig. 5 A and B). Such a reduction was also observed in
13-day-old Aβ42-expressing ﬂies after drug feeding with 100 nM
wortmannin for 7 days (Fig. S5C).
We were intrigued by such a dramatic effect. In particular, ﬁbril
deposits have been suggested to be critical in neurodegeneration
(24). Severe degeneration was evident in TS-staining images of
50-day-old male ﬂies with or without knocking down the P60
subunit (the black holes in Fig. 5A Lower). Then, we performed
H&E staining of the female brain slices at 40 days of age hoping
to more easily detect an improvement when the degeneration was
milder. We quantiﬁed the ratio of the degenerative areas within
the MB somatic region and used it to indicate the severity of
degeneration (8). There was no difference observed between
Aβ42-expressing ﬂies with or without silenced PI3K (Fig. 6).
Fig. 3. Inhibition of PI3K activity ameliorates the Aβ42-induced immediate
memory loss, whereas activation of PI3K activity causes an exacerbated
memory defect. (A and B) Expression of Aβ42 in ﬂy brains induced an
immediate memory loss compared with control ﬂies (elav/Y;UAS-Aβ42/+
versus +/Y;UAS-Aβ42/+) at 5 days old. The immediate memory was amelio-
rated through inhibition of PI3K activity with P60 RNAi (elav/Y;UAS-Aβ42/+;
UAS-dp60 RNAi/+) (A, t test; **P < 0.01) or overexpression of PTEN, a neg-
ative regulator of PI3K pathway (elav/Y;UAS-Aβ42/+;UAS-dpten/+) (B, t test;
*P < 0.05). Overexpression of the dominant negative PTENC124S in female
ﬂies exacerbated the Aβ42-induced memory loss at 5 days old. (elav/+;UAS-
Aβ42/+ versus elav/+;UAS-Aβ42/+;UAS-ptenC124S/+; C, t test; ***P < 0.001).
(D Left) Control ﬂies were fed with sucrose, whereas Aβ42-expressing ﬂies
were fed with sucrose or wortmannin. The Aβ42-induced memory loss was
ameliorated by treatment of 100 nM wortmannin (t test; **P < 0.01) but not
25 nM wortmannin. (Right) Drug treatment started 2 days after eclosion
(dae), and the immediate memory was tested at 10 dae. Data are expressed
as means ± SEM (n = 8-12 PIs as indicated).
Fig. 4. Inhibition of PI3K activity reduces the accumulation of Aβ42
oligomers. (Left) Aβ42 oligomer levels of indicated genotypes were detected
by Western blot with whole-head lyses of 15-day-old ﬂies. Arrows indicate
oligomer bands. Arrowhead indicates monomer band. (Right) Oligomers to
monomer ratios were calculated and normalized to Aβ42-expressing heads
(elav/Y;UAS-Aβ42/+). Aβ42 oligomer levels were reduced in ﬂy heads with
inhibited PI3K activity by either P60 RNAi or overexpressed PTEN (elav/Y;
UAS-Aβ42/+;UAS-dp60 RNAi/+ or elav/Y;UAS-Aβ42/+;UAS-dpten/+; t test;
*P < 0.05). Data are expressed as means ± SEM (n = 3 independent experi-
ments for each genotype).
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Thus, although inhibition of PI3K rescued early memory loss, it
had no effect on Aβ42-induced neurodegeneration.
Discussion
The goal of this study is to identify biochemical pathways
through which Aβ42 induces age-dependent memory loss. We
began by studying LTD at the larval NMJ, because this prepa-
ration is suitable for rapid testing of pharmacological and genetic
manipulations. It indeed provided a clue of PI3K hyperactivity.
We then moved to the ventral ganglion preparation that is
suitable for quantifying immunoreactivity of phospholipids. A
positive result of this study suggested that PI3K hyperactivity
might be a general feature of Aβ42 effects. We went on to show
that inhibition of PI3K activity could rescue Aβ42-induced
memory loss. This behavioral effect is correlated with a mild
reduction in the accumulation of Aβ42 oligomers as well as a
strong reduction in Aβ42 ﬁbril deposits.
The PI3K/Akt pathway has attracted attention for its pivotal
role in regulating cell survival, proliferation, and synaptic
transmission (25). Although several works have been reported in
studying its role in Aβ toxicity, the conclusions remained con-
troversial. In vitro studies show that application of Aβ42 reduced
Akt activity, and consequently, elevated Akt activity is capable of
reducing Aβ42-induced cell death in culture (26). However,
another study showed that acute exposure of primary mouse
neurons to Aβ42 up-regulated Akt phosphorylation (27). More
importantly, an increase in Akt activity was found in the tem-
poral cortex of the postmortem AD brain, suggesting an up-
regulated PI3K/Akt pathway in patients (28–30). Consistent with
the postmortem study, our in vivo analysis revealed that accu-
mulation of Aβ42 seemed to increase PI3K activity at the larval
NMJ, larval ganglion neurons, and the adult brain. This
enhanced activity was responsible for altered LTD, an abnormal
insulin response, and the age-dependent memory loss.
It is interesting to note that in patients, AD has been notori-
ously known as brain diabetes, because the brain tissue is shown
to be insulin resistant (31, 32). As indicated in this study, Aβ42-
stimulated PI3K can be an explanation of such resistance. The
basal level of PI3K was elevated to a level by an overloading of
Aβ42 so that insulin was unable to further stimulate its activity.
We speculate that restoring the dynamic range for PI3K activity,
but not simply inhibiting PI3K activity, could be responsible for
the rescued immediate memory.
In association with the rescued memory loss, we found a mild
reduction in accumulationofAβ42 oligomers and adrastic decrease
inﬁbril deposits. Interestingly, oral administration of PI3K inhibitor
also reduced the Aβ accumulation in mice (33). This is consistent
with reports that accumulation of Aβ oligomers is associated with
memory loss in mouse AD models, and injection of Aβ dimers
puriﬁed from AD patient brains into rat brain can cause memory
loss (2, 3, 22). It would be of interest to see if the reduced ﬁbril
deposits also contributed to the improved memory.
Materials and Methods
Drosophila Genetics and Stocks. Transgenic ﬂy lines used in this report have
been previously described, including UAS-Aβ42 (8, 13), elav C155-Gal4, G7-
Gal4 (34), UAS-dpten (35), and UAS-pten C124S (36). The UAS-p60 RNAi was
obtained from the Vienna Drosophila RNAi Center. Flies were raised and
maintained at room temperature (22–24 °C). All stocks used for Pavlovian
olfactory conditioning were equilibrated by ﬁve generations of out-cross to
w1118 (isoCJ1).
Electrophysiology. Two-electrodevoltage-clampelectrophysiologicalrecordings
were performed as described previously (17). In brief, wall-climbing third-instar
larvae were chosen for dissection. Larvae were dissected at room temperature
and inCa2+-freehemolymph-like (HL-3.1) solution (37) containing the following:
70 mM NaCl, 5 mM KCl, 4 mMMgCl2, 10 mM NaHCO3, 5 mM trehalose, 5 mM
Hepes, and 115 mM sucrose. All recordings were made at the longitudinal
muscles of segments A4–A5 and muscle ﬁber 12 with 0.4 mM CaCl2. The seg-
mental nerve was stimulated at 1.5 times the stimulus voltage required for a
threshold response forExcitatory JunctionCurrents (EJCs). For recordingsofLTD,
thenervewas stimulated atabaseline frequencyof 0.05Hz for 5minutes and30
Hz for induction of LTD. Current signals were ampliﬁed with an Axoclamp 2B
ampliﬁer (MolecularDevices). The signalswere digitizedusingaDigidata 1320A
interface (Molecular Devices) and acquired by pClamp 9.0 software (Molecular
Devices). To minimize variation, each experimental group was only compared
with a dedicated control group with a similar genetic background and was
recorded in the same batch of experiments. Evoked responses were analyzed
using the Mini Analysis Program (Synaptosoft).
Fig. 5. Reduced PI3K activity decreases Aβ42 ﬁbril deposits. (A) TS staining
was used to detect the Aβ42 ﬁbril deposits in the ﬂy brains. No deposits
were found in control brains (elav/Y;+/+; Top Right) at 15 dae. TS-positive
deposits (arrow) were found after Aβ42 expression in ﬂy brains (elav/Y;UAS-
Aβ42/+) at both 15 dae (Middle Left) and 50 dae (Bottom Left). Neuro-
degeneration in the brain was also been detected at 50 dae (arrowhead). (B)
Deposits were classiﬁed by the size into three groups: 1–1.5 μm, 1.5–2 μm,
and >2 μm. Genetic inhibition of PI3K by P60 RNAi (elav/Y;UAS-Aβ42/+;UAS-
dp60 RNAi/+) could reduce the deposit quantities of all of the three groups,
especially at 50 dae (t test; *P < 0.05; **P < 0.01). Data are expressed as
means ± SEM (n = 4 and 3 brains for 15 dae and 50 dae ﬂies, respectively).
(Scale bar, 25 μm.)
Fig. 6. Aβ42-induced neurodegeneration is not rescued by attenuation of
PI3K activity. Parafﬁn slices were taken from 40-day-old female ﬂies and
then, were stained with H&E. The MB somatic region is used to quantify the
severity of degeneration by calculating the ratio of degenerative area to
total area (histogram). Control ﬂies (elav/+;+/+) had entire cell-body region
at this age. Expression of Aβ42 in ﬂy brains induced neurodegeneration
(arrowhead) that was not recovered by inhibiting PI3K activity with P60 RNAi
(elav/+;UAS-Aβ42/+ versus elav/+;UAS-Aβ42/+;UAS-dp60 RNAi/+; t test; P >
0.05). Data are expressed as means ± SEM (n = 6 brains for each genotype).
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Lipid Analysis. Wall-climbing third-instar larvae were used for dissection.
Larvae were dissected at room temperature and in Ca2+-free HL-3.1 solution.
After incubation with 1.7 μM bovine insulin (Sigma) or 100 nM wortmannin
(Sigma) for 30 minutes, animals were ﬁxed with 4% paraformaldehyde
(Electron Microscopy Sciences) for 20 minutes and then changed to 0.5%
spatonin for 20 minutes. Samples were blocked with normal goat serum
(Jackson Immunoresearch Laboratories), incubated with mouse anti-PI3,4P
or mouse anti-PI3,4,5P antibodies (Echelon Biosciences) and then inspected
with the Zeiss LSM 510 confocal system. Five different cells from each gen-
otype were chosen for comparison by calculating the ﬂuorescence ratio of
the peripheral region to the central region. LSM 510 analysis software (Zeiss)
was used.
Pavlovian Olfactory Associative Immediate Memory. The training and testing
procedures were the same as previously described (38). During one training
session, a group of 100 ﬂies was sequentially exposed for 60 seconds to two
odors, 3-octanol (OCT; Fluka) or 4-methylcyclohexanol (MCH; Fluka), with 45
seconds of fresh air in between the exposure. Flies were subjected to foot
shock (1.5-second pulses with 3.5-second intervals; 60 V) during exposure to
the ﬁrst odor (CS+) but not during exposure to the second odor (CS−). To
measure immediate memory (also referred to as learning), ﬂies were
transferred immediately after training to the choice point of a T-maze and
were forced to choose between the two odors for 2 minutes. Then, ﬂies
were trapped in their respective T-maze arms, anesthetized, and counted. A
performance index (PI) was calculated from the distribution of this group of
ﬂies in the T-maze. A reciprocal group of ﬂies was trained and tested by
using OCT as the CS+ and MCH as the CS+, respectively. The so-called half-PIs
(OCT) and PI (MCH) were ﬁnally averaged for an n = 1 and multiplied by 100.
A PI of 0 indicated a distribution of 50:50 (no learning), whereas a PI of 100
indicated perfect learning (100% of the ﬂies avoided the CS+ previously
paired with foot shock). Control groups are age-matched to the exper-
imental groups in each test.
Sensorimotor Responses. Odor-avoidance (OA) responses were quantiﬁed by
exposing naïve ﬂies to one odor (OCT or MCH) versus air in the T-maze (38).
After 2 minutes, ﬂies were trapped in their respective T-maze arms, anes-
thetized, and counted. A PI was calculated for each odor individually as
reported (38). The ability to sense and escape from foot shock [shock reac-
tivity (SR)] was quantiﬁed in naïve ﬂies by inserting electriﬁable grids into
both arms of the T-maze and delivering shock pulses only in one arm of the
T-maze, allowing ﬂies to choose between the two arms. After 2 minutes,
ﬂies were trapped in their respective arms, anesthetized, and counted.
Individual PIs were calculated as for olfactory acuity.
Drug-Feeding Treatment. Wortmannin and LY294002 (Sigma) were dissolved
in DMSO (Sigma) and stored at −20 °C. Flies were starved for 3 hours in
empty vials and then fed with drugs, diluted in 4% sucrose, for another 4
hours. Flies were transferred to normal food after treatment. Drug feeding
was carried out one time each day during the treatment period. The ﬁnal
concentrations used were 25 nM/50 nM/100 nM for wortmannin and 30 μM
for LY294002.
Fibril Aβ42 Deposits Detection. TS (Sigma) staining was performed to detect
ﬁbril Aβ42 deposits as described previously (8, 23). Fly brains were ﬁxed in
4% paraformaldehyde and permeabilized by 2% triton. Brains were then
transferred to 0.25% TS in 50% ethanol for 1 night and destained for 10
minutes in 50% ethanol. After three washes with PBS, they were mounted
using focusclear (Pacgen Biopharmaceuticals Inc.), and coverslips were
added. Slides were inspected with a Zeiss LSM 510 confocal microscope. LSM
510 analysis software was used.
Western Blot Analysis. Whole-head lyses were diluted in SDS sample buffer,
separated by 10–20% Tris-Tricine gels (Invitrogen), and transferred to
nitrocellulose membranes (Invitrogen). The membranes were boiled in PBS
for 3 minutes, blocked with 5% nonfat dry milk, and blotted with the 6E10
antibody (Covance Research Products). Data were analyzed with software
ImageJ (National Institutes of Health).
Quantiﬁcation of Neurodegeneration. Heads were ﬁxed in 4% paraf-
ormaldehyde, processed to embed in parafﬁn blocks, and sectioned at a
thickness of 6 μm. Sections were placed on slides, stained with H&E (Vector),
and examined by bright-ﬁeld microscopy. The area of the vacuoles in the
mushroom-body cell-body region was measured in each image with soft-
ware ImageJ. The ratio was calculated by dividing the sum of the vacuole
areas by the total area of the cell-body region.
Statistical Analysis. All data were analyzed by using Student t tests (SigmaPlot
version 10.0; Systat Software Inc.). Statistical results are presented as means ±
SEM. Asterisks indicate critical values (*P< 0.05; **P< 0.01, and ***P< 0.001).
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